Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

santen sa - netarsudilum, latanoprostum - collyre en solution - netarsudilum 0.2 mg ut netarsudili dimesilas, latanoprostum 0.05 mg, mannitolum, acidum boricum, benzalkonii chloridum 0.2 mg, natrii hydroxidum ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - glaucome à angle ouvert, hypertension oculaire - synthetika

Unjoni Ewropea - Bulgaru - EMA (European Medicines Agency)

santen oy - netarsudil - glaucoma, open-angle; ocular hypertension - Офталмологични - Намаляване на повишено вътреочното налягане (ВОН) при възрастни пациенти с първична откритоъгълна глаукома или очна хипертония.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 61561 - body femoral/tibial extension stem, uncoated - composed of tial6v4 with silver coating. provides coupling of a component with a mutars taper connection to a component with a mutars cylindrical fit connection. it has a male mutars cylindrical and serration connection at one end and a female mutars taper connection at the other end. the coupling is 28 mm in diameter and 30 mm in length. an 8 mm diameter internal mutars coupling device screw is applied across the connection to secure the connection. a component of the mutars system intended to provide an adapter coupling between components in the femoral region. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 61006 - humeral stem extension prosthesis - composed of tial6v4 with silver coating. the connection piece consists of two parts: the mutars connecting part distal & connecting part proximal. the two parts are connected with the mutars screw for connecting part. uses the mutars cylindrical fit & serration connection for attachment to the mutars humerus head, reducer piece, connecting part, end piece, stem, distal humerus & proximal ulna. the connecting part has 1 retention ring for securing a pet mesh soft tissue attachment tube. a component of the mutars system intended as an extraosseous length adjustment in the area of the humerus for the bridging of bone defects. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 33178 - revision uncoated hip femur prosthesis - composed of titanium alloy tial6v4 with silver coating. proximal femur component of the mutars (modular universal tumor and revision system) system in two different lengths of 50 mm and 70 mm with taper (12/14), with retention rings for fixation of the attachment tube and various stems. the treatment can be adjusted with the use of the extension pieces of 20 mm increments. the proximal femur allows the adjustment of the antetorsion angles in 5 degree increments. proximal femoral replacement component of the mutars system indicated for tumours in the area of the proximal femur or other major bone defects including hip joint arthroplasty as hemi prosthesis or total hip replacement. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.